Table 2 Cancer-related gene expression profiling benchmarks
From: iRDA: a new filter towards predictive, stable, and enriched candidate genes
Dataset | Class | Samples | Genes | IR | Source |
|---|---|---|---|---|---|
1. Brain | GBM/AO | 50 (28/22) | 12,625 | 1.27 | (Nutt et al., 2003 [54]) |
2. CNS | Survivor/failure | 60 (21/39) | 7129 | 1.86 | (Pomeroy et al., 2002 [55]) |
3. Colon | Negative/positive | 62 (40/22) | 2000 | 1.82 | (Alon et al., 1999 [49]) |
4. Leukemia | ALL/AML | 72 (47/25) | 7129 | 1.88 | (Golub et al., 1999 [56]) |
5. Lung | MPM/ADCA | 181 (31/150) | 12,533 | 4.84 | (Gordon et al., 2002 [57]) |
6. Lymphoma | DLBCL/FL | 77 (58/19) | 7129 | 3.05 | (Shipp et al., 2002 [58]) |
7. Prostate | Tumor/normal | 102 (52/50) | 12,600 | 1.04 | (Singh et al., 2002 [59]) |